Investigators developed and validated a masked autoencoder deep learning model using vision transformer technology to automate the detection and grading of nuclear cataracts from slit-lamp images.

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Some companies now offer multi-cancer early detection ...

With March being colon cancer awareness month, it’s a good time to look at some startling numbers on the disease here in the United States. Once considered only a medical concern for middle-age or ...

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The ...

A new kind of blood test promises to find cancer early – sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at ...

A man in a car looks down at his phone. “No cancer signal detected,” says a message on the screen. The man closes his eyes and smiles in relief. Why are so many young people getting cancer? What the ...

Originally from Northern California, Dr. Sam Asgarian came to love New Orleans while volunteering for cleanup post-Hurricane Katrina. His goal was always to become a primary care provider, wanting to ...

Dr. McDreamy has signed onto yet another cancer awareness initiative. “Grey’s Anatomy” star Patrick Dempsey, who has worked with Amgen since 2007 and joined forces with Pfizer in 2024, is now ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...